Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Dengue
Human papillomavirus (HPV)
SAGE documentation
2022
2018
GRADE table
Clear all
Type of publications
SAGE documentation
(6)
Topics
GRADE table
(6)
Regions
Countries
Diseases
Dengue
(5)
Human papillomavirus (HPV)
(1)
COVID-19
(2)
Hepatitis A
(1)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
2022
(1)
2018
(5)
2024
(1)
2014
(1)
2008
(1)
Available to download in languages
English (EN)
(6)
6 results found
2022
∙
SAGE
Should an off-label , permissive one-dose HPV vaccine schedule for use in routine and/or multi-age cohort (MAC) catch up strategies be recommended?
2018
∙
SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seronegative individuals 9-16 years of age in the first year following vaccination?
2018
∙
SAGE
What is the efficacy of 3 doses of CYD-TDV in preventing clinical dengue in seropositive individuals 9-16 years of age in the first year following vaccination?
2018
∙
SAGE
What is the duration of protection/risk in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?
2018
∙
SAGE
What is the duration of protection/risk in seronegative individuals 9-16 years of age vaccinated with CYD-TDV?
2018
∙
SAGE
What is the risk of other serious adverse events (non-dengue) in seropositive individuals 9-16 years of age vaccinated with CYD-TDV?
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register